GlassScriptPhysician profile
Craig Saran
NPI 1508125709
$13,813.82
in general payments reported to CMS, 2019-2025
30 companies · $3,341 in 2025
The $3,341 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,887 · 2020: $849 · 2021: $1,214 · 2022: $614 · 2023: $1,072 · 2024: $3,837 · 2025: $3,341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,649 · Travel and Lodging: $1,490 · Consulting Fee: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,649.07 |
| Travel and Lodging | $1,489.96 |
| Consulting Fee | $1,110.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,944.76 | 2019-2025 | Intracept, Na, Click |
| Vertiflex, INC. | $2,047.99 | 2019 | |
| Biotronik Nro, INC. | $1,694.55 | 2024-2025 | Prospera |
| Nalu Medical, INC. | $1,412.69 | 2021-2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $995.80 | 2019-2020 | |
| Medtronic, INC. | $405.94 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Vertos Medical, INC. | $306.49 | 2023-2024 | Mild Device Kit |
| Nuvasive, INC. | $304.30 | 2021-2023 | Xlif |
| Nevro Corp. | $289.53 | 2019-2023 | Senza |
| Stryker Corporation | $247.57 | 2021-2025 | Mild Device Kit |
| Painteq LLC | $222.72 | 2022-2024 | Painteq |
| Abbvie INC. | $180.72 | 2021-2025 | Qulipta |
| Abbott Laboratories | $158.00 | 2021-2024 | Octrode |
| Teva Pharmaceuticals USA, INC. | $86.01 | 2019-2020 | |
| Relievant Medsystems, INC. | $58.94 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $56.83 | 2019-2025 | |
| Spr Therapeutics, INC | $51.56 | 2019 | |
| Foundation Fusion Solutions, LLC | $45.10 | 2024-2025 | |
| Pfizer INC. | $37.62 | 2023 | |
| Tonix Medicines, INC. | $36.67 | 2025 | Tonmya |
| Saluda Medical Americas, INC. | $34.51 | 2024 | Evoke |
| Avanos Medical | $33.68 | 2025 | Generator |
| Allergan, INC. | $28.45 | 2020-2021 | |
| Lilly USA, LLC | $26.83 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $23.33 | 2021 | |
| Valinor Pharma, LLC | $22.27 | 2023 | Movantik |
| Vertex Pharmaceuticals Incorporated | $20.34 | 2025 | |
| Janssen Biotech, INC. | $14.57 | 2019 | |
| Bausch Health US, LLC | $13.97 | 2019 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Saran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.